Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Alp, Keziban Merve (1) Birchmeier, Walter Prof. Dr. (7) Blankenstein, Thomas Prof. Dr. (2) Blüthgen, Nils (1) Dahlmann, Mathias Dr. (29) Daniel, Peter Prof. Dr. (3) Haas, Simon Dr. rer. nat. (1) Hartl, Kimberly (1) Herse, Florian PD Dr. (1) Holz, Maximilian (1) Horne, Arik (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Janke, Jürgen Dr. (1) Janz, Martin Dr. (1) Kobelt, Dennis Dr. (51) Koch, Gudrun (1) Leutz, Achim Prof. Dr. (2) Na, Il-Kang Dr. (1) Nazare, Marc (1) Nguyen, Tam Hoai Dr. (1) Nimptsch, Katharina Dr. (1) Özerdem, Ceren (1) Pezzutto, Antonio Prof. Dr. (4) Pischon, Tobias Prof. Dr. (1) Popp, Oliver Dr. (3) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Röefzaad, Claudia (1) Schlag, Peter M. Prof. Dr. (378) Schmitt, Clemens Prof. Dr. (2) Schöpe, Paul Curtis (2) Schroeder, Leif Dr. (1) Simon, Mareike Dr. (1) Smith, Janice (17) Solé Boldo, Llorenc Dr. rer. nat. (1) Specker, Edgar Dr. (2) Sperling, Silke Prof. Dr. (1) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (189) Torke, Sebastian Dr. (4) Uckert, Wolfgang Prof. Dr. (1) Veltsista, Paraskevi Danai (2) von Kries, Jens Peter Dr. (2) Walther, Wolfgang Prof. Dr. (147) Wenzel, Katrin Dr. (1) Willimsky, Gerald Dr. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) Zimmermann, Karin Dr. (1) (-) Fritsche, Raphaela Dr. (2) (-) Malchin, Victoria (1) (-) Mertins, Philipp Dr. (4) 2010 (2) 2019 (1) 2021 (3) 2022 (1) Advanced Light Microscopy (1) AG Müller/Dechend (ECRC) (1) AG Schreiber [ECRC] (1) Anchored Signalling (1) Animal Phenotyping (1) Bioinformatics and Omics Data Science (2) Biology of Malignant Lymphomas (2) Cancer Genetics and Cellular Stress Responses (1) Cellular Neurosciences (8) Computational Regulatory Genomics (2) Developmental Biology / Signal Transduction (1) Electron Microscopy (2) Flow Cytometry (2) Genetics and Genomics of Cardiovascular Diseases (7) Genetics of Congenital Heart Disease (1) Genome Diversification & Integrity (2) Genome Engineering & Disease Models (2) Host-microbiome factors in cardiovascular disease (6) Hypertension-caused End-Organ Damage (1) Hypertension-Mediated End-Organ Damage (1) Immune Regulation and Cancer (4) Intracellular Proteolysis (1) Mathematical Cell Physiology (2) Mathematical Modelling of Cellular Processes (2) Mechanism-based Cancer Therapies (3) Molecular Biology of Peptide Hormones (1) Molecular Cardiovascular Research (4) Molecular Immunology and Gene Therapy (3) Molecular Oncology (1) Myology (1) Nephrology and Inflammatory Vascular Diseases (1) Non-coding RNAs and Mechanisms of Cytoplasmic Gene Regulation (1) Organoids (2) Pluripotent Stem Cells (2) Protein Production and Characterization (1) Proteome Dynamics (5) Proteomics (125) Proteomics and Metabolomics (38) Psychoneuroimmunology (5) RNA Biology and Posttranscriptional Regulation (12) Synaptic Transmission and Plasticity (2) Systems Biology Imaging (2) Systems Biology of Gene Regulatory Elements (11) Systems Hematology, Stem Cells & Precision Medicine (1) Transgenics (2) Translational Bioinformatics (13) Translational Cardiology and Functional Genomics (4) (-) Translational Oncology of Solid Tumors (7) Tumor heterogeneity and treatment resistance in pediatric cancer (1) 7 Results: Active Filter: Fritsche, Raphaela Dr.Malchin, VictoriaMertins, Philipp Dr.Translational Oncology of Solid Tumors Sort: Result score Newest to oldest Oldest to newest December, 2010 / Histopathology Therapeutic potential of CAMPATH-1H in skeletal tumours R. Fritsche-Guenther A. Gruetzkau A. Noske I. Melcher K.D. Schaser P.M. Schlag H.U. Kasper V. Krenn C. Sers December, 2010 / Histopathology De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signalling pathway R. Fritsche-Guenther A. Noske U. Ungethuem R.J. Kuban P.M. Schlag P.U. Tunn J. Karle V. Krenn M. Dietel C. Sers February 23, 2022 / Nat Commun Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma Y.L.D. Ng E. Ramberger S.R. Bohl A. Dolnik C. Steinebach T. Conrad S. Müller O. Popp M. Kull M. Haji M. Gütschow H. Döhner W. Walther U. Keller L. Bullinger P. Mertins J. Krönke February, 2019 / Life Sci Alliance A C/EBPα-Wnt connection in gut homeostasis and carcinogenesis J. Heuberger U. Hill S. Förster K. Zimmermann V. Malchin A.A. Kühl U. Stein M. Vieth W. Birchmeier A. Leutz January, 2021 / Neoplasia Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine M. Rivera I. Fichtner A. Wulf-Goldenberg C. Sers J. Merk G. Patone K.M. Alp T. Kanashova P. Mertins J. Hoffmann U. Stein W. Walther October 21, 2021 / Mol Cancer Peritoneal metastasis of colorectal cancer (pmCRC): identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models M. Dahlmann G. Gambara B. Brzezicha O. Popp E. Pachmayr L. Wedeken A. Pflaume M. Mokritzkij S. Gül-Klein A. Brandl C. Schweiger-Eisbacher P. Mertins J. Hoffmann U. Keilholz W. Walther C. Regenbrecht B. Rau U. Stein August 26, 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein
December, 2010 / Histopathology Therapeutic potential of CAMPATH-1H in skeletal tumours R. Fritsche-Guenther A. Gruetzkau A. Noske I. Melcher K.D. Schaser P.M. Schlag H.U. Kasper V. Krenn C. Sers
December, 2010 / Histopathology De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signalling pathway R. Fritsche-Guenther A. Noske U. Ungethuem R.J. Kuban P.M. Schlag P.U. Tunn J. Karle V. Krenn M. Dietel C. Sers
February 23, 2022 / Nat Commun Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma Y.L.D. Ng E. Ramberger S.R. Bohl A. Dolnik C. Steinebach T. Conrad S. Müller O. Popp M. Kull M. Haji M. Gütschow H. Döhner W. Walther U. Keller L. Bullinger P. Mertins J. Krönke
February, 2019 / Life Sci Alliance A C/EBPα-Wnt connection in gut homeostasis and carcinogenesis J. Heuberger U. Hill S. Förster K. Zimmermann V. Malchin A.A. Kühl U. Stein M. Vieth W. Birchmeier A. Leutz
January, 2021 / Neoplasia Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine M. Rivera I. Fichtner A. Wulf-Goldenberg C. Sers J. Merk G. Patone K.M. Alp T. Kanashova P. Mertins J. Hoffmann U. Stein W. Walther
October 21, 2021 / Mol Cancer Peritoneal metastasis of colorectal cancer (pmCRC): identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models M. Dahlmann G. Gambara B. Brzezicha O. Popp E. Pachmayr L. Wedeken A. Pflaume M. Mokritzkij S. Gül-Klein A. Brandl C. Schweiger-Eisbacher P. Mertins J. Hoffmann U. Keilholz W. Walther C. Regenbrecht B. Rau U. Stein
August 26, 2021 / Oncogene The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis D. Kobelt D. Perez-Hernandez C. Fleuter M. Dahlmann F. Zincke J. Smith R. Migotti O. Popp S. Burock W. Walther G. Dittmar P. Mertins U. Stein